Trajectories of Medical Prescription Opioid Use in Middle Adulthood and Substance Use Disorder Symptoms
Psychiatric Services · 2026
DOI: 10.1176/appi.ps.20250392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatric Services, 2026. Verfasst von Sean Esteban McCabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Study of Drugs, Alcohol, Smoking and Health, University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: Analgesics, Opioid, Opioid-Related Disorders, Prescription Drug Misuse, Substance-Related Disorders. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
OBJECTIVE: Major changes in opioid prescribing have created a need to understand long-term patterns of medical prescription opioid use and its associations with substance-related consequences. This study aimed to identify trajectories of medical use of prescription opioids during middle adulthood (ages 35-60) and examine associations of such trajectories with nonmedical prescription opioid use and substance use disorder symptoms. METHODS: Twenty-seven cohorts of 31,094 adults were followed longitudinally via self-administered surveys during midlife. Latent profile analysis was used to create trajectory profiles based on frequency of medical prescription opioid use between ages 35 and 60. RESULTS: An estimated 37.3% of adults reported at least one episode of medical prescription opioid use during midlife, and four trajectories were identified: infrequent use (27.1% of all adults); multiple peaks at ages 35, 45, and 60 (3.7%); multiple peaks at ages 40 and 55 (2.9%); and frequent use at all ages (3.7%). The prevalence and adjusted odds ratio (AOR) of experiencing multiple substance use disorder symptoms were significantly higher among adults with frequent use at all ages (60.5%, AOR=2.1); multiple peaks at ages 35, 45, and 60 (51.1%, AOR=1.7); multiple peaks at ages 40 and 55 (48.9%, AOR=1.5); and infrequent use (41.1%, AOR=1.4), relative to a population control group. CONCLUSIONS: Most adults with frequent long-term medical use of prescription opioids reported multiple substance use disorder symptoms. Screening for nonmedical use and substance use disorders before prescribing opioids and ongoing monitoring for substance use disorders are critical, particularly among adults requiring frequent or long-term recurrent medical use of prescription opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for the Study of Drugs, Alcohol, Smoking and Health, University of Michigan, Ann Arbor.
- Institute for Social Research, University of Michigan, Ann Arbor.
- Jane Addams College of Social Work, University of Illinois Chicago, Chicago.
- Department of Psychiatry, Massachusetts General Hospital, Boston.
- Harvard Medical School, Harvard University, Boston.
- Department of Psychiatry, University of Michigan, Ann Arbor.
Förderung
- NIDA NIH HHS
Zitieren
APA
McCabe, S. E., Pasman, E., Wilens, T. E., Overton Gunnar Hoffman, E., Schepis, T. S., Jardine, J., Dickinson, K., Wang, A., & Veliz, P. (2026). Trajectories of Medical Prescription Opioid Use in Middle Adulthood and Substance Use Disorder Symptoms. Psychiatric Services. https://doi.org/10.1176/appi.ps.20250392
Vancouver
McCabe SE, Pasman E, Wilens TE, Overton Gunnar Hoffman E, Schepis TS, Jardine J, et al. Trajectories of Medical Prescription Opioid Use in Middle Adulthood and Substance Use Disorder Symptoms. Psychiatric Services. 2026. doi:10.1176/appi.ps.20250392
BibTeX
@article{McCabe2026,
author = {McCabe, Sean Esteban and Pasman, Emily and Wilens, Timothy E and Overton Gunnar Hoffman, Elizabeth and Schepis, Ty S and Jardine, John and Dickinson, Kara and Wang, Anna and Veliz, Philip},
title = {Trajectories of Medical Prescription Opioid Use in Middle Adulthood and Substance Use Disorder Symptoms},
journal = {Psychiatric Services},
year = {2026},
doi = {10.1176/appi.ps.20250392}
}
EUVIMED